Abstract
Viable human embryos carrying a disease mutation have now been corrected by CRISPR-Cas9 editing. Although the correction is not perfect, and the embryos have not been implanted, this brings us closer to human germline editing and to the associated ethical questions.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have